C Moro, R Taino, M Mandalà, R Labianca. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Acute DiseaseAdultAnalgesics, Opioid/adverse effectsAntineoplastic Agents, Alkylating/therapeutic useBuprenorphine/adverse effectsHumansIfosfamide/therapeutic useMaleOsteosarcoma/complicationsOsteosarcoma/drug therapyOsteosarcoma/surgeryPain/complicationsPain/drug therapyPelvic Neoplasms/complicationsPelvic Neoplasms/drug therapyPelvic Neoplasms/secondaryRespiratory Insufficiency/chemically inducedRespiratory Insufficiency/etiologySkull Neoplasms/complicationsSkull Neoplasms/drug therapySkull Neoplasms/surgery
Substances： See more » Analgesics, OpioidAntineoplastic Agents, AlkylatingBuprenorphineIfosfamide
Year: 2006 PMID： 16641169 DOI： 10.1093/annonc/mdl059
Source DB: PubMed Journal: Ann Oncol ISSN： 0923-7534 Impact factor: 32.976